N-aryl-β-carbolin derivatives and uses thereof

A technology of carbolin and derivatives, applied in the field of N-aryl-β-carbolin derivatives, which can solve the problem of long synthesis steps, low yield and purity, and insufficient activity against cardiomyocyte hypoxia-reoxygenation injury Significant problems, to achieve the effect of simple steps and simple synthesis method

Active Publication Date: 2021-06-22
GUIZHOU MEDICAL UNIV
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are currently 4 isomers, among which 3-carboline is also called β-carboline and β-carbolin. Its natural products have a series of biological activities such as anti-inflammatory, bactericidal, cytotoxic, and anti-cancer properties. In the document "Regulatory Effects of β-Carboline and Feridone Alkaloids on Inflammatory Signal Transduction Pathways", it is reported that β-carbolin alkaloids have anti-HIV, anti-inflammatory, antibacterial, and inhibitory activities of monoammonia oxidase etc. Patent No. CN201910584227.8 Extraction process and application of β-carbolin-type alkaloids in bitterwood, discloses the application of β-carbolin-type alkaloids in bitterwood for the preparation of anti-tumor drugs; but at present, most Most β-carbolins are obtained by extracting natural substances, and the yield and purity are extremely low, which seriously affects their development and application, and there are few studies on the anti-myocardial hypoxia-reoxygenation injury of β-carbolin derivatives
[0004] Patent No. CN201810124764X reported that α-carbolin derivatives have anti-hypoxia-reoxygenation injury activity in cardiomyocytes. However, the synthesis steps of α-carbolin’s mother nucleus are long and the yield is low, especially when benzotriazole is used in multiple Removal of N under the action of polyphosphoric acid 2 The yield of α-carborine obtained by ring closure after the molecule is only about 20%, and the total yield is lower than 10%, which limits the development of carbolin derivatives. At the same time, studies have shown that the cardiomyocyte toxicity of α-carborin derivatives is relatively large, and the anti-cardiomyocyte hypoxia-reoxygenation injury activity is not significant enough, which seriously restricts the application of carbolin derivatives in cardiomyocyte protection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • N-aryl-β-carbolin derivatives and uses thereof
  • N-aryl-β-carbolin derivatives and uses thereof
  • N-aryl-β-carbolin derivatives and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0069] The preparation of embodiment 1 compound 6

[0070] Weigh dry, 4.58mmol of L-tryptophan methyl ester hydrochloride 1.0g, and 9.16mmol, 40% acetaldehyde 403.69mg, dissolve in dichloromethane 20mL, then add 11.45mmol of trifluoroacetic acid 1.57g, room temperature The reaction was stirred under low temperature, and the reaction was detected by TLC until the reaction was completely terminated, 60 mL of water was added, extracted with dichloromethane, and the organic layer was spin-dried to obtain a crude product, which was purified by normal phase silica gel column chromatography to obtain compound 3 with a yield of 85%;

[0071] Weigh 31.0 g of dry 4.09 mmol of compound into a 100 mL eggplant-shaped bottle, add 15 mL of DMF solvent, and slowly add 8.19 mmol of KMnO at 0°C 4 1.29 g, after the addition, continue to stir and react at 0°C for 1 h, place at room temperature to continue the reaction, use TLC to detect that the reaction is complete, stop the reaction, filter wit...

Embodiment 2

[0074] Compound 7——Preparation of N-(4-fluorobenzyl)-1-ethyl-3-methoxyl-β-carbolin

[0075] Referring to the preparation of compound 6, 1-methyl-3-methoxyacyl-β-carbolin was replaced with 1-ethyl-3-methoxyl-β-carbolin, and the yield was 63%;

[0076] Therefore, the preparation of 1-ethyl-3-methoxyl-β-carbolin (that is, compound 5) is to replace acetaldehyde in the preparation process of compound 4 with propionaldehyde.

Embodiment 3

[0078] Compound 8——Preparation of N-(4-bromobenzyl)-1-ethyl-3-methoxyacyl-β-carbolin

[0079] Referring to the preparation of compound 6, 4-fluorobromobenzyl was replaced by 4-bromobromobenzyl, and the yield was 59%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to the field of pharmaceutical technology, in particular to N-aryl-β-carbolin derivatives and uses thereof; the synthesis method of the N-aryl-β-carbolin derivatives of the present invention is simple, and the steps are simple and convenient. First use tryptophan methyl ester and aldehyde derivatives to react to obtain indolopyrrole intermediates, then add an oxidant to obtain β-carbolin, and finally couple aromatic ring derivatives under alkaline conditions to obtain the β-carbolin of the present invention. N-aryl-β-carbolin derivatives have low cardiomyocyte toxicity, strong protective ability and high activity, which improves the application of carbolin derivatives in myocardial hypoxia-reoxygenation injury.

Description

technical field [0001] The invention relates to the technical field of medicines, in particular to N-aryl-β-carbolin derivatives and applications thereof. Background technique [0002] Coronary atherosclerotic heart disease is one of the most common diseases that threaten human health, and its incidence is on the rise. Nowadays, cardiovascular and cerebrovascular diseases have become the main diseases leading to human death. Ischemic heart disease is reported to be the leading cause of mortality worldwide, accounting for 8 million deaths in 2013. At present, the main means of treating coronary atherosclerosis is to quickly open the arteries related to myocardial blockage, so that the coronary artery bypass graft can be reperfused. However, studies have found that these treatments are accompanied by myocardial ischemia-reperfusion injury (MI / RI), which leads to further damage to myocardial cells. MIRI has become one of the important factors leading to death due to myocardia...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D471/04A61K31/437A61K31/444A61P9/00A61P9/10
CPCA61P9/00A61P9/10C07D471/04
Inventor 周孟张红王珊廖祥明廖尚高张荣红徐国波何迅关焕玉董永喜王磊马良会李勇军王永林
Owner GUIZHOU MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products